Biliary sterol secretion is not required for macrophage reverse cholesterol transport

Ryan E. Temel; Janet K. Sawyer; Liqing Yu; Caleb Lord; Chiara Degirolamo; Allison McDaniel; Stephanie Marshall; Nanping Wang; Ramesh Shah; Lawrence L. Rudel; J. Mark Brown

doi:10.1016/j.cmet.2010.05.011

Biliary sterol secretion is not required for macrophage reverse cholesterol transport

Ryan E. Temel
, Janet K. Sawyer
, Liqing Yu
, Caleb Lord
, Chiara Degirolamo
, Allison McDaniel
, Stephanie Marshall
, Nanping Wang
, Ramesh Shah
, Lawrence L. Rudel
, J. Mark Brown

Producción científica: Article › revisión exhaustiva

99 Citas (Scopus)

Resumen

Recent evidence suggests that the intestine may play a direct facilitative role in reverse cholesterol transport (RCT), independent of hepatobiliary secretion. In order to understand the nonbiliary pathway for RCT, we created both genetic and surgical models of biliary cholesterol insufficiency. To genetically inhibit biliary cholesterol secretion, we generated mice in which Niemann-Pick C1-Like 1 (NPC1L1) was overexpressed in the liver. Compared to controls, NPC1L1^Liver-Tg mice exhibit a >90% decrease in biliary cholesterol secretion, yet mass fecal sterol loss and macrophage RCT are normal. To surgically inhibit biliary emptying into the intestine, we have established an acute biliary diversion model. Strikingly, macrophage RCT persists in mice surgically lacking the ability to secrete bile into the intestine. Collectively, these studies demonstrate that mass fecal sterol loss and macrophage RCT can proceed in the absence of biliary sterol secretion, challenging the obligate role of bile in RCT.

Idioma original	English
Páginas (desde-hasta)	96-102
Número de páginas	7
Publicación	Cell Metabolism
Volumen	12
N.º	1
DOI	https://doi.org/10.1016/j.cmet.2010.05.011
Estado	Published - jul 7 2010

Nota bibliográfica

Funding Information:
We sincerely thank Paul Dawson (Wake Forest University) for critical reading of this manuscript and providing meaningful input into these studies. We also thank George Rothblat (The Children's Hospital of Philadelphia) for providing J774 macrophages. This work was supported by the National Heart, Lung, and Blood Institute through a pathway to independence grant (1K99-HL096166 to J.M.B.) and a program project grant (5P01HL049373 to L.L.R.). L.Y. is supported by a Scientist Development Grant (#0635261N) from the American Heart Association. L.L.R. is a member of the Merck speaker's bureau.

Financiación

We sincerely thank Paul Dawson (Wake Forest University) for critical reading of this manuscript and providing meaningful input into these studies. We also thank George Rothblat (The Children's Hospital of Philadelphia) for providing J774 macrophages. This work was supported by the National Heart, Lung, and Blood Institute through a pathway to independence grant (1K99-HL096166 to J.M.B.) and a program project grant (5P01HL049373 to L.L.R.). L.Y. is supported by a Scientist Development Grant (#0635261N) from the American Heart Association. L.L.R. is a member of the Merck speaker's bureau.

Financiadores	Número del financiador
National Heart, Lung, and Blood Institute (NHLBI)	0635261N, 1K99-HL096166, P01HL049373
American Heart Association

ASJC Scopus subject areas

Physiology
Molecular Biology
Cell Biology

Acceder al documento

10.1016/j.cmet.2010.05.011

Otros archivos y enlaces

Citar esto

@article{2f77db4b1f8746cf8e8818f1b4b69ec3,

title = "Biliary sterol secretion is not required for macrophage reverse cholesterol transport",

abstract = "Recent evidence suggests that the intestine may play a direct facilitative role in reverse cholesterol transport (RCT), independent of hepatobiliary secretion. In order to understand the nonbiliary pathway for RCT, we created both genetic and surgical models of biliary cholesterol insufficiency. To genetically inhibit biliary cholesterol secretion, we generated mice in which Niemann-Pick C1-Like 1 (NPC1L1) was overexpressed in the liver. Compared to controls, NPC1L1Liver-Tg mice exhibit a >90\% decrease in biliary cholesterol secretion, yet mass fecal sterol loss and macrophage RCT are normal. To surgically inhibit biliary emptying into the intestine, we have established an acute biliary diversion model. Strikingly, macrophage RCT persists in mice surgically lacking the ability to secrete bile into the intestine. Collectively, these studies demonstrate that mass fecal sterol loss and macrophage RCT can proceed in the absence of biliary sterol secretion, challenging the obligate role of bile in RCT.",

keywords = "HUMDISEASE",

author = "Temel, \{Ryan E.\} and Sawyer, \{Janet K.\} and Liqing Yu and Caleb Lord and Chiara Degirolamo and Allison McDaniel and Stephanie Marshall and Nanping Wang and Ramesh Shah and Rudel, \{Lawrence L.\} and Brown, \{J. Mark\}",

note = "Funding Information: We sincerely thank Paul Dawson (Wake Forest University) for critical reading of this manuscript and providing meaningful input into these studies. We also thank George Rothblat (The Children's Hospital of Philadelphia) for providing J774 macrophages. This work was supported by the National Heart, Lung, and Blood Institute through a pathway to independence grant (1K99-HL096166 to J.M.B.) and a program project grant (5P01HL049373 to L.L.R.). L.Y. is supported by a Scientist Development Grant (\#0635261N) from the American Heart Association. L.L.R. is a member of the Merck speaker's bureau. ",

year = "2010",

month = jul,

day = "7",

doi = "10.1016/j.cmet.2010.05.011",

language = "English",

volume = "12",

pages = "96--102",

number = "1",

}

TY - JOUR

T1 - Biliary sterol secretion is not required for macrophage reverse cholesterol transport

AU - Temel, Ryan E.

AU - Sawyer, Janet K.

AU - Yu, Liqing

AU - Lord, Caleb

AU - Degirolamo, Chiara

AU - McDaniel, Allison

AU - Marshall, Stephanie

AU - Wang, Nanping

AU - Shah, Ramesh

AU - Rudel, Lawrence L.

AU - Brown, J. Mark

N1 - Funding Information: We sincerely thank Paul Dawson (Wake Forest University) for critical reading of this manuscript and providing meaningful input into these studies. We also thank George Rothblat (The Children's Hospital of Philadelphia) for providing J774 macrophages. This work was supported by the National Heart, Lung, and Blood Institute through a pathway to independence grant (1K99-HL096166 to J.M.B.) and a program project grant (5P01HL049373 to L.L.R.). L.Y. is supported by a Scientist Development Grant (#0635261N) from the American Heart Association. L.L.R. is a member of the Merck speaker's bureau.

PY - 2010/7/7

Y1 - 2010/7/7

N2 - Recent evidence suggests that the intestine may play a direct facilitative role in reverse cholesterol transport (RCT), independent of hepatobiliary secretion. In order to understand the nonbiliary pathway for RCT, we created both genetic and surgical models of biliary cholesterol insufficiency. To genetically inhibit biliary cholesterol secretion, we generated mice in which Niemann-Pick C1-Like 1 (NPC1L1) was overexpressed in the liver. Compared to controls, NPC1L1Liver-Tg mice exhibit a >90% decrease in biliary cholesterol secretion, yet mass fecal sterol loss and macrophage RCT are normal. To surgically inhibit biliary emptying into the intestine, we have established an acute biliary diversion model. Strikingly, macrophage RCT persists in mice surgically lacking the ability to secrete bile into the intestine. Collectively, these studies demonstrate that mass fecal sterol loss and macrophage RCT can proceed in the absence of biliary sterol secretion, challenging the obligate role of bile in RCT.

AB - Recent evidence suggests that the intestine may play a direct facilitative role in reverse cholesterol transport (RCT), independent of hepatobiliary secretion. In order to understand the nonbiliary pathway for RCT, we created both genetic and surgical models of biliary cholesterol insufficiency. To genetically inhibit biliary cholesterol secretion, we generated mice in which Niemann-Pick C1-Like 1 (NPC1L1) was overexpressed in the liver. Compared to controls, NPC1L1Liver-Tg mice exhibit a >90% decrease in biliary cholesterol secretion, yet mass fecal sterol loss and macrophage RCT are normal. To surgically inhibit biliary emptying into the intestine, we have established an acute biliary diversion model. Strikingly, macrophage RCT persists in mice surgically lacking the ability to secrete bile into the intestine. Collectively, these studies demonstrate that mass fecal sterol loss and macrophage RCT can proceed in the absence of biliary sterol secretion, challenging the obligate role of bile in RCT.

KW - HUMDISEASE

UR - https://www.scopus.com/pages/publications/77956642596

UR - https://www.scopus.com/pages/publications/77956642596#tab=citedBy

U2 - 10.1016/j.cmet.2010.05.011

DO - 10.1016/j.cmet.2010.05.011

M3 - Article

C2 - 20620999

AN - SCOPUS:77956642596

SN - 1550-4131

VL - 12

SP - 96

EP - 102

JO - Cell Metabolism

JF - Cell Metabolism

IS - 1

ER -

Biliary sterol secretion is not required for macrophage reverse cholesterol transport

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto